BANK VONTOBEL/CALL/MEDTRONIC/90/0.1/21.06.24 Share Price

Warrant

DE000VM676G4

Market Closed - Boerse Frankfurt Warrants 11:23:03 24/05/2024 pm IST
0.004 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/MEDTRONIC/90/0.1/21.06.24
Current month-82.61%
1 month-80.95%
Date Price Change
24/24/24 0.004 0.00%
23/24/23 0.004 -94.03%
22/24/22 0.067 0.00%
21/24/21 0.067 +9.84%
20/24/20 0.061 -23.75%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 11:23 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VM676G
ISINDE000VM676G4
Date issued 18/12/2023
Strike 90 $
Maturity 21/06/2024 (28 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.44
Lowest since issue 0.003
Spread 0.019
Spread %82.61%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
82.29 USD
Average target price
94.74 USD
Spread / Average Target
+15.13%
Consensus